, FEV 1 , and Fractional Exhaled Nitric Oxide

Background. Asthma education is an important adjunct for asthma control although the way asthma education affects asthma outcomes is poorly understood. The asthma control test (ACT), forced expiratory volume in 1 s (FEV1), and fractional exhaled nitric oxide (FeNO) have all been used as markers of asthma control. However, the use of FeNO as a surrogate marker remains controversial. Objectives. (i) To examine whether asthma education is associated with asthma control; (ii) to compare absolute levels and changes of ACT, FEV1, and FeNO over a year; and (iii) to evaluate whether FeNO can be used as an additional marker of asthma control.Methods. Fifty asthmatics with poor adherence (12mild, 21 moderate, and 17 severe) received asthma education at study entry. Medications were unchanged for the first 3 months, and ACT, FEV1, and FeNO measurements were recorded at entry, 3, 6, and 12 months. Asthma control was assessed at each visit and patients were categorized as either “stable” or “unstable” asthmatics according to the global initiative for asthma (GINA) guidelines.Results.A significant decrease in FeNO and increase in ACT score were noted in the stable asthmatic group at 3 months (p < .001), and this persisted over 12 months. Significant correlations were seen between changes (Δ) in FeNO, ACT, and FEV1 over time. However, significant correlations between the absolute levels were not maintained over 12 months. A decrease of 18.6% in FeNO and a 3-point increase in ACT score (sensitivity: 80% and 73.3% and specificity: 83.3% and 87.5%, respectively) were associated with stable asthma control although the absolute levels were not. Conclusions. Asthma education may be useful to achieve stable control. In addition, changes rather than absolute levels of FeNO and ACT may be better markers of asthma control.

[1]  M J Hensley,et al.  Self-management education and regular practitioner review for adults with asthma. , 2002, The Cochrane database of systematic reviews.

[2]  M. Munakata,et al.  Clinical usefulness of fractional exhaled nitric oxide for diagnosing prolonged cough. , 2008, Respiratory medicine.

[3]  S. Janson,et al.  Individualized asthma self-management improves medication adherence and markers of asthma control. , 2009, The Journal of allergy and clinical immunology.

[4]  Lee Stern,et al.  Medication compliance and disease exacerbation in patients with asthma: a retrospective study of managed care data. , 2006, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[5]  J. Paton,et al.  Measuring compliance with inhaled medication in asthma. , 1992, Archives of disease in childhood.

[6]  H. Sintonen,et al.  Long-term economic evaluation of intensive patient education during the first treatment year in newly diagnosed adult asthma. , 2001, Respiratory medicine.

[7]  R. Hancox,et al.  The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control. , 2001, American journal of respiratory and critical care medicine.

[8]  D. Nowak,et al.  Educational intervention decreases exhaled nitric oxide in farmers with occupational asthma , 2007, European Respiratory Journal.

[9]  M. Munakata,et al.  Off-Line Fractional Exhaled Nitric Oxide Measurement Is Useful to Screen Allergic Airway Inflammation in an Adult Population , 2007, The Journal of asthma : official journal of the Association for the Care of Asthma.

[10]  Junpei Saito,et al.  Exhaled nitric oxide as a marker of airway inflammation for an epidemiologic study in schoolchildren. , 2004, The Journal of allergy and clinical immunology.

[11]  S. Bosnic-Anticevich,et al.  Pharmacy Asthma Care Program (PACP) improves outcomes for patients in the community , 2007, Thorax.

[12]  R. Haynes,et al.  Interventions for enhancing medication adherence. , 2008, The Cochrane database of systematic reviews.

[13]  W. Hop,et al.  Daily telemonitoring of exhaled nitric oxide and symptoms in the treatment of childhood asthma. , 2009, American journal of respiratory and critical care medicine.

[14]  L. Corbetta,et al.  The need to improve inhalation technique in Europe: a report from the Aerosol Drug Management Improvement Team. , 2006, Respiratory medicine.

[15]  R. Pauwels,et al.  GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION , 1996 .

[16]  Mark Kosinski,et al.  The minimally important difference of the Asthma Control Test. , 2009, The Journal of allergy and clinical immunology.

[17]  Mike Thomas,et al.  Cluster analysis and clinical asthma phenotypes. , 2008, American journal of respiratory and critical care medicine.

[18]  J. Cowan,et al.  Exhaled nitric oxide levels in asthma: Personal best versus reference values. , 2009, The Journal of allergy and clinical immunology.

[19]  A. Chang,et al.  A systematic review and meta-analysis: tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils) , 2010, Thorax.

[20]  A. Michils,et al.  Exhaled nitric oxide and asthma control: a longitudinal study in unselected patients , 2008, European Respiratory Journal.

[21]  C. Rand,et al.  The Madison Avenue effect: how drug presentation style influences adherence and outcome in patients with asthma. , 2011, The Journal of allergy and clinical immunology.

[22]  J. Cowan,et al.  Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. , 2005, The New England journal of medicine.

[23]  Bernadette Bouchon-Meunier,et al.  Patients' perception of asthma severity. , 2007, Respiratory medicine.

[24]  P. Gergen,et al.  Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial , 2008, The Lancet.

[25]  R. Horne Compliance, adherence, and concordance: implications for asthma treatment. , 2006, Chest.

[26]  Effect of an individualised education programme on asthma control, inhaler use skill, asthma knowledge and health-related quality of life among poorly compliant Korean adult patients with asthma. , 2011, Journal of clinical nursing.

[27]  I. Pavord,et al.  Exhaled nitric oxide in pulmonary diseases: a comprehensive review. , 2010, Chest.

[28]  R. Louis,et al.  Association between asthma control and bronchial hyperresponsiveness and airways inflammation: a cross‐sectional study in daily practice , 2009, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[29]  I. Pavord,et al.  Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial , 2002, The Lancet.

[30]  W. Hop,et al.  Titrating steroids on exhaled nitric oxide in children with asthma: a randomized controlled trial. , 2005, American journal of respiratory and critical care medicine.